Plus Therapeutics Inc (NASDAQ: PSTV) is -89.95% lower on its value in year-to-date trading and has touched a low of $0.16 and a high of $2.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.18 in the last trading session, with the day’s gains setting it 7.61%.
Currently trading at $7.79M, the stock is -37.23% and -61.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 120.5 million and changing 120499436% at the moment leaves the stock -81.95% off its SMA200. PSTV registered -83.74% loss for a year compared to 6-month loss of -81.30%. The firm has a 50-day simple moving average (SMA 50) of $0.4874 and a 200-day simple moving average (SMA200) of $1.03605.
The stock witnessed a -40.26% gain in the last 1 month and extending the period to 3 months gives it a -83.60%, and is -39.46% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.95% over the week and 12.12% over the month.
Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $9.54M and $5.21M in sales. Profit margin for the company is -520.90%. Distance from 52-week low is 14.44% and -91.90% from its 52-week high.
The EPS is expected to grow by 62.87% this year.
Plus Therapeutics Inc (PSTV) Top Institutional Holders
17.0 institutions hold shares in Plus Therapeutics Inc (PSTV), with institutional investors hold 4.29% of the company’s shares. The shares outstanding are 51.00M, and float is at 46.47M with Short Float at 1.10%. Institutions hold 3.90% of the Float.
The top institutional shareholder in the company is AIGH CAPITAL MANAGEMENT LLC with over 0.57 million shares valued at $0.84 million. The investor’s holdings represent 8.7478% of the PSTV Shares outstanding. As of 2024-06-30, the second largest holder is GEODE CAPITAL MANAGEMENT, LLC with 46648.0 shares valued at $68572.0 to account for 0.7176 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 32541.0 shares representing 0.5006% and valued at over $47835.0, while CITADEL ADVISORS LLC holds 0.2812 of the shares totaling 18283.0 with a market value of $26876.0.
Plus Therapeutics Inc (PSTV) Insider Activity
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).
